Ufp Technologies (UFPT) Liabilities and Shareholders Equity (2010 - 2026)
Ufp Technologies' (UFPT) quarterly Liabilities and Shareholders Equity came in at $674.7 million in Q1 2026, up 4.99% YoY from $642.6 million in Q1 2025, and up 2.99% on a QoQ basis from $655.1 million in Q4 2025.
Ufp Technologies (UFPT) Liabilities and Shareholders Equity (2010 - 2026) Analysis & Trends
Ufp Technologies (UFPT) has 17 years of Liabilities and Shareholders Equity data on file, last reported at $674.7 million in Q1 2026.
- Quarterly Liabilities and Shareholders Equity rose 4.99% year-over-year to $674.7 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $2.6 billion (up 12.21% YoY) and the FY2025 annual result came in at $655.1 million, up 4.15% from the prior year.
- Liabilities and Shareholders Equity climbed to $674.7 million in Q1 2026, from $655.1 million in the prior quarter.
- In the past five years, Liabilities and Shareholders Equity ranged from a high of $674.7 million in Q1 2026 to a low of $363.3 million in Q1 2022.
- A 5-year average of $498.5 million and a median of $407.7 million in 2024 frame the typical range for Liabilities and Shareholders Equity.
- Annual changes were most pronounced in 2022 — Liabilities and Shareholders Equity soared 81.81% — and 2023, when it rose 0.74%.
- Tracing UFPT's Liabilities and Shareholders Equity over 5 years: stood at $378.2 million in 2022, then gained by 6.86% to $404.1 million in 2023, then surged by 55.64% to $629.0 million in 2024, then gained by 4.15% to $655.1 million in 2025, then climbed by 2.99% to $674.7 million in 2026.
- The last three Liabilities and Shareholders Equity figures came in at $674.7 million (Q1 2026), $655.1 million (Q4 2025), and $652.8 million (Q3 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Liabilities and Shareholders Equity (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 198.70 Bn | 193.10 Bn | 7.27 Bn | 109.22 Bn |
| 2 | Stryker | 125.85 Bn | 122.37 Bn | 4.50 Bn | 47.93 Bn |
| 3 | Medtronic | 118.44 Bn | 109.22 Bn | 6.41 Bn | 93.03 Bn |
| 4 | Boston Scientific | 72.64 Bn | 72.10 Bn | 3.85 Bn | 45.22 Bn |
| 5 | Edwards Lifesciences | 51.94 Bn | 47.69 Bn | 1.35 Bn | 13.87 Bn |
| 6 | Dexcom | 34.48 Bn | 32.53 Bn | 830.00 Mn | 6.46 Bn |
| 7 | GE HealthCare Technologies | 33.60 Bn | 31.49 Bn | 2.18 Bn | 37.25 Bn |
| 8 | Koninklijke Philips | 26.30 Bn | 22.98 Bn | 4.55 Bn | 31.04 Bn |
| 9 | Steris | 23.00 Bn | 22.52 Bn | 684.20 Mn | 10.74 Bn |
| 10 | Ufp Technologies | 2.34 Bn | 2.33 Bn | 50.92 Mn | 681.91 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 681.91 Mn |
| Mar 31, 2026 | 674.68 Mn |
| Dec 31, 2025 | 655.08 Mn |
| Sep 30, 2025 | 652.82 Mn |
| Jun 30, 2025 | 634.66 Mn |
| Mar 31, 2025 | 642.64 Mn |
| Dec 31, 2024 | 629.00 Mn |
| Sep 30, 2024 | 638.51 Mn |
| Jun 30, 2024 | 422.40 Mn |
| Mar 31, 2024 | 407.68 Mn |
| Dec 31, 2023 | 404.14 Mn |
| Sep 30, 2023 | 399.81 Mn |
| Jun 30, 2023 | 397.99 Mn |
| Mar 31, 2023 | 390.78 Mn |
| Dec 31, 2022 | 378.19 Mn |
| Sep 30, 2022 | 388.32 Mn |
| Jun 30, 2022 | 395.05 Mn |
| Mar 31, 2022 | 363.35 Mn |
| Dec 31, 2021 | 334.13 Mn |
| Sep 30, 2021 | 220.69 Mn |